Myomo (MYO) Other financing activities (2016 - 2024)
Myomo (MYO) posted Other financing activities of -$4.6 million for Q4 2024, down 200.0% on a QoQ basis from $4.6 million in Q1 2024, and up 30.49% year-over-year from -$3.5 million in Q1 2024.
Myomo (MYO) Other financing activities (2016 - 2024) Analysis & Trends
Myomo's Other financing activities history runs 8 years deep, the most recent figure standing at -$4.6 million for Q4 2024.
- Quarterly Other financing activities rose 30.49% year-over-year to -$4.6 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$4.6 million (down 128.03% YoY) and the FY2023 annual result came in at $8116.0, changed N/A from the prior year.
- Other financing activities was -$4.6 million for Q4 2024 at Myomo, down from $4.6 million in the prior quarter.
- Across five years, Other financing activities topped out at $13.5 million in Q4 2020 and bottomed at -$6.6 million in Q4 2023.
- A 4-year average of $2.6 million and a median of $4.2 million in 2023 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2020 — Other financing activities slumped 97.14% — and 2021, when it soared 4418.52%.
- Myomo's Other financing activities stood at $13.5 million in 2020, then sank by 64.61% to $4.8 million in 2021, then tumbled by 238.41% to -$6.6 million in 2023, then surged by 30.49% to -$4.6 million in 2024.
- Business Quant data shows MYO's Other financing activities at -$4.6 million in Q4 2024, $4.6 million in Q1 2024, and -$6.6 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -4.60 Mn |
| Dec 31, 2024 | -4.60 Mn |
| Mar 31, 2024 | 4.60 Mn |
| Mar 31, 2024 | 4.60 Mn |
| Dec 31, 2023 | -6.62 Mn |
| Dec 31, 2023 | -6.62 Mn |
| Sep 30, 2023 | 6.63 Mn |
| Sep 30, 2023 | 6.63 Mn |
| Jun 30, 2023 | -3.72 Mn |
| Jun 30, 2023 | -3.72 Mn |
| Mar 31, 2023 | 3.71 Mn |
| Mar 31, 2023 | 3.71 Mn |
| Dec 31, 2021 | 4.78 Mn |
| Dec 31, 2021 | 4.78 Mn |
| Sep 30, 2021 | 4.80 Mn |
| Sep 30, 2021 | 4.80 Mn |
| Mar 31, 2021 | 7.29 Mn |
| Mar 31, 2021 | 7.29 Mn |
| Dec 31, 2020 | 13.50 Mn |
| Dec 31, 2020 | 13.50 Mn |